Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03296072 · ClinicalTrials.gov registry record · Phase 3
In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste
A Phase 3 study of Tooth Erosion, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 62
- Enrollment target
- 1
- Study location
NCT03296072 is a Phase 3 study of Tooth Erosion that has completed, run by GlaxoSmithKline. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03296072, a Phase 3 study of Tooth Erosion, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, controlled, single center, single- blind, 3 period, 3 treatment, cross-over, in situ design which consists of placing pre-eroded bovine enamel specimens intra orally using a palatal appliance and testing the remineralizing performance of the experimental (dentifrice containing 0.254 Percent weight by weight \[%, w/w\] sodium fluoride (1150 parts per million \[ppm\] fluoride) and 5% KNO3 \[potassium nitrate\]), comparator (dentifrice containing 0.454% w/w stannous fluoride (1100 ppm fluoride) and placebo (Fluoride free placebo containing 5% KNO3 \[0 ppm fluoride\] ) dentifrices 2 and 4 hours (hrs) post treatment application, based on surface micro hardness measurements. This study will be carried out in healthy adults with a maxillary dental arch suitable for the retention of the palatal appliance.
Conditions Studied
Interventions
- DRUG 0.254% w/w sodium fluoride and 5% KNO3
- DRUG 0.454% w/w stannous fluoride
- DRUG 5% KNO3
Study Locations (1)
Indiana
- GSK Investigational Site - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2018-01-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03296072
The ClinicalTrials.gov registry entry for NCT03296072 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tooth Erosion appearing as the primary indexed condition, and to 3 interventions - of which 0.254% w/w sodium fluoride and 5% KNO3 is the first listed.
NCT03296072 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03296072 about?
NCT03296072 is a clinical study titled "In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste". This will be a randomized, controlled, single center, single- blind, 3 period, 3 treatment, cross-over, in situ design which consists of placing pre-eroded bovine enamel specimens intra orally using a palatal appliance and testing the remineralizing performance of the experimental (dentifrice contai...
What is the current status of trial NCT03296072?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2017-11-13. Estimated completion is 2018-01-16.
What conditions does trial NCT03296072 study?
This clinical trial studies the following conditions: Tooth Erosion.
What interventions are being tested in trial NCT03296072?
The interventions under investigation include: 0.254% w/w sodium fluoride and 5% KNO3 (DRUG), 0.454% w/w stannous fluoride (DRUG), 5% KNO3 (DRUG).
Who is sponsoring clinical trial NCT03296072?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03296072 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tooth Erosion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.